CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Budapest, Hungary and 541 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Budapest, Hungary and 195 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Budapest, Hungary and 555 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Budapest, Hungary and 342 other locations
Clinical trials
Research sites
Resources
Legal